ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Dishman May Sell Shanghai Site

by Jean-François Tremblay
February 13, 2012 | APPEARED IN VOLUME 90, ISSUE 7

Indian pharmaceutical chemicals producer Dishman Group is considering the sale of its Chinese manufacturing site. Located in the Shanghai Chemical Industry Park, the facility can produce highly potent active pharmaceutical ingredients. The plant is in working order, but Dishman is no longer committed to a manufacturing site in China, says Christian Dowdeswell, the firm’s global director of custom pharmaceuticals. The company has experienced regulatory delays and other hurdles in China and may concentrate most manufacturing activities in India, Dowdeswell explains. All options remain open at the moment, including retaining the site, he adds.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment